Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens

Authors:

Abstract
Multivalent presentation of viral glycoproteins can substantially increase the elicitation of antigen-specific antibodies. To enable a new generation of anti-viral vaccines, we designed self-assembling protein nanoparticles with geometries tailored to present the ectodomains of influenza, HIV, and RSV viral glycoprotein trimers. We first de novo designed trimers tailored for antigen fusion, featuring N-terminal helices positioned to match the C termini of the viral glycoproteins. Trimers that experimentally adopted their designed configurations were incorporated as components of tetrahedral, octahedral, and icosahedral nanoparticles, which were characterized by cryo-electron microscopy and assessed for their ability to present viral glycoproteins. Electron microscopy and antibody binding experiments demonstrated that the designed nanoparticles presented antigenically intact prefusion HIV-1 Env, influenza hemagglutinin, and RSV F trimers in the predicted geometries. This work demonstrates that antigen-displaying protein nanoparticles can be designed from scratch, and provides a systematic way to investigate the influence of antigen presentation geometry on the immune response to vaccination.
Funding Information
  • Bill and Melinda Gates Foundation (OPP1120319)
  • Bill and Melinda Gates Foundation (OPP1111923)
  • Bill and Melinda Gates Foundation (OPP1156262)
  • Bill and Melinda Gates Foundation (OPP1115782)
  • Bill and Melinda Gates Foundation (OPP1084519)
  • National Science Foundation (NSF CHE 1629214)
  • National Center for Research Resources (5P41RR015301-10)
  • National Institute of General Medical Sciences (P41 GM103403-10)
  • National Institute of General Medical Sciences (P30 GM124169-01)
  • National Institute of General Medical Sciences (High-End Instrumentation Grant S10OD018483)
  • U.S. Department of Energy (Contract No. DE-AC02-05CH11231)
  • The Audacious Project
  • National Institute of Allergy and Infectious Diseases (HIVRAD P01 AI 110657)

This publication has 78 references indexed in Scilit: